Treatment of patients with primary Sjogren's syndrome with rituximab is efficient according to the EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI)

被引：0
|
作者：
Vissink, A. [1 ]
Moerman, R. V. [2 ]
Arends, S. [2 ]
Meiners, P. M. [1 ]
Meijer, J. M. [1 ]
Kroese, F. G. M. [2 ]
Spijkervet, F. K. L. [1 ]
Bootsma, H. [2 ]
机构：
[1] Univ Groningen, Dept Oral & Maxillofacial Surg, Univ Med Ctr Groningen, Groningen, Netherlands
[2] Univ Groningen, Dept Rheumatol & Clin Immunol, Univ Med Ctr Groningen, Groningen, Netherlands
来源：
ORAL DISEASES | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Rituximab Therapy for Primary Sjogren's Syndrome
    Chen, Yi Han
    Wang, Xin Yu
    Jin, Xin
    Yang, Zi
    Xu, Jianguang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [32] Rituximab Therapy in Primary Sjogren's Syndrome
    Alcantara, Cristina
    Gomes, Maria Joao
    Ferreira, Carlos
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 701 - 705
  • [33] EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) Is Increased In Sjogren's Syndrome Patient With Fibromyalgia
    Valim, Valeria
    Miyamoto, Samira T.
    Paganotti, Mauricio
    Serrano, Erica V.
    Altoe, Raquel
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S225 - S226
  • [34] Haematologic indices and disease activity index in primary Sjogren's syndrome
    Yildiz, Fatih
    Gokmen, Onur
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (03)
  • [35] Sleep apnea in Sjogren's syndrome potentially influences the EULAR Sjogren's syndrome patient reported index
    Juelich, Maike
    Budweiser, Stephan
    Thoden, Jan
    Voll, Reinhard E.
    Kollert, Florian
    MODERN RHEUMATOLOGY, 2019, 29 (03) : 563 - 565
  • [36] Successful treatment of a patient with primary Sjogren's syndrome with Rituximab
    Ring, Troels
    Kallenbach, Maria
    Praetorius, Jeppe
    Nielsen, Soren
    Melgaard, Birgitte
    CLINICAL RHEUMATOLOGY, 2006, 25 (06) : 891 - 894
  • [37] Maintenance of rituximab treatment in a patient with primary Sjogren's syndrome
    Lehner, Georg Franz
    Brunner-Palka, Malgorzata
    Rettenbacher, Thomas
    Schmidauer, Regina
    Herold, Manfred
    RHEUMATOLOGY, 2014, 53 (07) : 1349 - 1350
  • [38] Do the EULAR Sjogren's syndrome outcome measures correlate with health status in primary Sjogren's syndrome?
    Lendrem, Dennis
    Mitchell, Sheryl
    McMeekin, Peter
    Gompels, Luke
    Hackett, Katie
    Bowman, Simon
    Price, Elizabeth
    Pease, Colin T.
    Emery, Paul
    Andrews, Jacqueline
    Lanyon, Peter
    Hunter, John
    Gupta, Monica
    Bombardieri, Michele
    Sutcliffe, Nurhan
    Pitzalis, Costantino
    McLaren, John
    Cooper, Annie
    Regan, Marian
    Giles, Ian
    Isenberg, David
    Saravanan, Vadivelu
    Coady, David
    Dasgupta, Bhaskar
    McHugh, Neil
    Young-Min, Steven
    Moots, Robert
    Gendi, Nagui
    Akil, Mohammed
    Griffiths, Bridget
    Ng, Wan-Fai
    Registry, Uk Primary Sjogren's Syndrome
    RHEUMATOLOGY, 2015, 54 (04) : 655 - 659
  • [39] Efficacy of retreatment with rituximab in patients with primary Sjogren's syndrome
    Meiners, P. M.
    Arends, S.
    Meijer, J. M.
    Moerman, R. V.
    Spijkervet, F. K. L.
    Vissink, A.
    Bootsma, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : 443 - 443
  • [40] Accurate Detection of Changes in Disease Activity in Primary Sjogren's Syndrome by the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index
    Seror, Raphaele
    Mariette, Xavier
    Bowman, Simon
    Baron, Gabriel
    Gottenberg, Jacques Eric
    Boostma, Hendrika
    Theander, Elke
    Tzioufas, Athanasios
    Vitali, Claudio
    Ravaud, Philippe
    ARTHRITIS CARE & RESEARCH, 2010, 62 (04) : 551 - 558
12345